+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1000 Pages
  • Global
From
From
From
Next-Generation Antibody Therapeutics Market Report 2025 - Product Thumbnail Image

Next-Generation Antibody Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
From
From
From
Acute Ischemic Stroke Drugs Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator